Pierre Aman Selected Research

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

12/2013

A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Aman Research Topics

Disease

12	Neoplasms (Cancer) 10/2015 - 01/2003
8	Myxoid Liposarcoma 10/2015 - 02/2002
5	Sarcoma (Soft Tissue Sarcoma) 12/2013 - 11/2004
4	Liposarcoma 10/2015 - 04/2004
2	Leukemia 12/2013 - 07/2008
1	Frontotemporal Dementia (Semantic Dementia) 12/2013
1	Nervous System Diseases (Neurological Disorders) 12/2013
1	Essential Tremor (Essential Tremors) 12/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2013
1	Epidermolysis Bullosa 03/2012
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2008
1	Astrocytoma (Pilocytic Astrocytoma) 12/2007
1	Lipoma (Lipomata) 01/2007
1	Fibrosarcoma 07/2005
1	Glioma (Gliomas) 05/2005
1	Brain Neoplasms (Brain Tumor) 05/2005
1	Chondrosarcoma 03/2003
1	Extraskeletal Myxoid Chondrosarcoma 03/2003
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2003
1	Carcinogenesis 01/2002
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2002
1	Teratoma (Teratoid Tumor) 01/2002

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2014 - 02/2002
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 06/2010
2	Oncogene Proteins (Oncogene Protein)IBA 12/2013 - 12/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2008 - 11/2004
2	Phosphotransferases (Kinase)IBA 01/2008 - 11/2004
2	Oncostatin MIBA 12/2007 - 05/2005
2	Complementary DNA (cDNA)IBA 11/2004 - 03/2003
1	tanespimycin (17AAG)IBA 10/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2015
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 10/2015
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	HeterochromatinIBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	RNA Precursors (Precursor, mRNA)IBA 03/2012
1	PlectinIBA 03/2012
1	LigandsIBA 06/2010
1	Prostaglandins FIBA 06/2010
1	Cyclin-Dependent Kinase 2IBA 12/2009
1	Transcription Factor CHOPIBA 02/2009
1	TrabectedinIBA 02/2009
1	OligonucleotidesIBA 02/2008
1	Tyrosine Kinase InhibitorsIBA 01/2008
1	Gefitinib (Iressa)FDA Link 01/2008
1	vandetanib (ZD6474)IBA 01/2008
1	Interleukin-6 (Interleukin 6)IBA 07/2005
1	CytokinesIBA 07/2005
1	CCAAT-Enhancer-Binding Protein-betaIBA 07/2005
1	RNA Splicing FactorsIBA 07/2005
1	Messenger RNA (mRNA)IBA 07/2005
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2004
1	CyclinsIBA 11/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2004
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2004
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2003
1	Glycoproteins (Glycoprotein)IBA 03/2003
1	Biological ProductsIBA 01/2003
1	Tumor Biomarkers (Tumor Markers)IBA 01/2003
1	Histidine (L-Histidine)FDA Link 01/2002
1	fragile histidine triad proteinIBA 01/2002
1	Dihydrotachysterol (AT 10)IBA 01/2002

Therapy/Procedure

1	Therapeutics 10/2015
1	Radiotherapy 01/2007